The dragon is flying high today as Merck hits go on a second immunotherapy candidate from its $700 million pact with Dragonfly…
Need help?
Contact usThe dragon is flying high today as Merck hits go on a second immunotherapy candidate from its $700 million pact with Dragonfly…